Trial Information

Summary: Advanced Solid Tumors Study CLBH589B2111

Novartis is conducting this clinical trial is to find out the effect that food has on a study drug called LBH589 as well as the overall effect that the study drug has on participants with advanced solid tumors that has progressed despite treatment. An "investigational drug" is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).

Participants will be asked to visit the study doctor's office for a screening visit, then 3 to 4 times a week for the first 3 weeks for treatment and/or evaluation, and then 1 to 2 times a week for evaluation every week thereafter. Each visit should take about 1-3 hours, however on some days participants will be in the office for approximately 8 to 10 hours.
For more information about this clinical trial, visit www.NovartisClinicalTrials.com

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 27, 2008 at 1:00:23 PM